The Wilhelm Sander Foundation is funding sixteen new cancer research projects with over 2.8 million euros

In the third quarter of 2026, the Wilhelm Sander Foundation approved funding for 16 research projects totalling 2,824,168 euros. These range from the targeted induction of ferroptosis in pancreatic cancer, through new immunotherapies for leukaemias and lymphomas, to gentler radiotherapy techniques. Funding is being provided for projects that fundamentally elucidate the mechanisms underlying cancer development and resistance to treatment, and which use these findings to derive new diagnostic and therapeutic approaches.